股票 › XERS
塞里斯制药 XERS
美股市值排名 #2532
$15.20 +$2.12 (+16.21%)
休市 · Nov 7, 10:10 pm ET · 最新盘后价 $15.15 -0.33%
开盘$13.79
昨收$13.08
当日区间$13.53 – $15.21
成交量7.90M
市值$2.78B
市盈率（TTM）–
股息率–
XERS 相关新闻
匹配 Xeris Pharmaceuticals 或代码 XERS 的头条新闻，按最新排序。
- Craig-Hallum Maintains Xeris Pharmaceuticals(XERS.US) With Buy Rating, Maintains Target Price $12
- H.C. Wainwright Remains a Buy on Xeris Pharmaceuticals (XERS)
- H.C. Wainwright Maintains Xeris Pharmaceuticals(XERS.US) With Buy Rating, Maintains Target Price $10
- Piper Sandler Maintains Xeris Pharmaceuticals(XERS.US) With Hold Rating, Maintains Target Price $8
- Leerink Partners Maintains Xeris Pharmaceuticals(XERS.US) With Buy Rating, Raises Target Price to $16 正面
- Barclays Maintains Xeris Pharmaceuticals(XERS.US) With Buy Rating, Raises Target Price to $12 正面
- Craig-Hallum Maintains Xeris Pharmaceuticals(XERS.US) With Buy Rating, Announces Target Price $12
- Craig-Hallum Maintains Xeris Pharmaceuticals(XERS.US) With Buy Rating
- Barclays Maintains Xeris Pharmaceuticals(XERS.US) With Buy Rating, Maintains Target Price $9
- Analysts Offer Insights on Healthcare Companies: Prime Medicine, Inc. (PRME) and Xeris Pharmaceuticals (XERS)
- Barclays Maintains Xeris Pharmaceuticals(XERS.US) With Buy Rating, Raises Target Price to $14 正面
- Xeris Pharmaceuticals (XERS) Receives a Buy From H.C. Wainwright
- Craig-Hallum Maintains Xeris Pharmaceuticals(XERS.US) With Buy Rating, Announces Target Price $11
- Oppenheimer Maintains Xeris Pharmaceuticals(XERS.US) With Buy Rating, Raises Target Price to $8 正面
- Leerink Partners Maintains Xeris Pharmaceuticals(XERS.US) With Buy Rating, Announces Target Price $9
暂无评论——快来第一个聊聊 XERS。
登录后参与讨论。